norfluoxetine has been researched along with Body Weight in 5 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine treatment reversed MDMA-induced anxiety in the emergence test and depressive-like effects in the forced swim test, yet exhibited no effects on the social interaction test." | 5.32 | Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. ( Clemens, KJ; Cornish, JL; Gurtman, CG; Hunt, GE; Li, KM; McGregor, IS; Thompson, MR, 2004) |
| "Fluoxetine treatment reversed MDMA-induced anxiety in the emergence test and depressive-like effects in the forced swim test, yet exhibited no effects on the social interaction test." | 1.32 | Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. ( Clemens, KJ; Cornish, JL; Gurtman, CG; Hunt, GE; Li, KM; McGregor, IS; Thompson, MR, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Able, JA | 2 |
| Liu, Y | 1 |
| Jandacek, R | 2 |
| Rider, T | 2 |
| Tso, P | 2 |
| McNamara, RK | 2 |
| Pawluski, JL | 1 |
| van Donkelaar, E | 1 |
| Abrams, Z | 1 |
| Houbart, V | 1 |
| Fillet, M | 1 |
| Steinbusch, HW | 1 |
| Charlier, TD | 1 |
| Thompson, MR | 1 |
| Li, KM | 1 |
| Clemens, KJ | 1 |
| Gurtman, CG | 1 |
| Hunt, GE | 1 |
| Cornish, JL | 1 |
| McGregor, IS | 1 |
| Caccia, S | 1 |
| Confalonieri, S | 1 |
| Bergami, A | 1 |
| Fracasso, C | 1 |
| Anelli, M | 1 |
| Garattini, S | 1 |
5 other studies available for norfluoxetine and Body Weight
| Article | Year |
|---|---|
Omega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: association with altered 5-HT1A and alpha2A adrenergic receptor expression.
Topics: alpha-Linolenic Acid; Animals; Body Weight; Brain; Diet; Fatty Acids, Omega-3; Fluoxetine; Male; Mot | 2014 |
Fluoxetine dose and administration method differentially affect hippocampal plasticity in adult female rats.
Topics: Animals; Blood Glucose; Body Weight; CA3 Region, Hippocampal; Dose-Response Relationship, Drug; Estr | 2014 |
Effect of chronic fluoxetine treatment on male and female rat erythrocyte and prefrontal cortex fatty acid composition.
Topics: Animals; Antidepressive Agents, Second-Generation; Body Weight; Chromatography, Gas; Chromatography, | 2010 |
Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Body Fluids; Body Temperature; Body Weig | 2004 |
Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine.
Topics: Administration, Oral; Animals; Appetite Depressants; Body Weight; Brain Chemistry; Catecholamines; D | 1997 |